Booster jab creates ‘significant protection’ against Omicron, Israeli study confirms
Third jab increases neutralisation of Omicron variant 100-fold compared to two doses
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.A new study from Israel has confirmed a third booster dose of the Pfizer vaccine provides “significant protection” against the Omicron variant of Covid.
In findings similar to those already reported by Pfizer itself, researchers at the Sheba Medical Centre and the Israeli Health Ministry concluded a third booster dose of the vaccine does enable the body to resist the mutated Omicron strain of coronavirus.
In the study, doctors looked at the blood of 20 people who had received the standard two doses of the vaccine five to six months ago and then compared this to the 20 people who had been boosted within the last month.
When the Omicron variant virus was introduced to the samples from just the double-jabbed people, their immune systems did not have any noticeable ability to attack the virus.
However, when the boosted samples were also tested with Omicron, there was a huge leap in immune response.
"People who received the second dose 5 or 6 months ago do not have any neutralization ability against the Omicron. While they do have some against the Delta (strain)," said Gili Regev-Yochay, director of the Infectious Diseases Unit at the Sheba Medical Centre, told reporters.
"The good news is that with the booster dose it increases about a hundred-fold. There is a significant protection of the booster dose.
However, she did add the booster dose was four times more effective against the Delta variant, than Omicron.
Pfizer’s lab tests earlier this month showed similar results, further underlining the need for a third booster jab to sustain immune protection.
However, another part of the body’s immune response – the T-cells generated by vaccination which also help fight off Covid – do not wane in the same way as antibodies and are still able to neutralise Omicron despite its many mutations.
That indicates “vaccinated individuals may still be protected against severe forms of the disease” after only two doses, Pfizer said.
As a result of the growing evidence of the need for a third dose, the British government has announced a target to offer every adult a booster jab by the end of the year.
In a televised address on Sunday night, the prime minister Boris Johnson warned that the UK was “facing an emergency in our battle with the new variant, Omicron”.
Mr Johnson said he was launching a “national mission” to get everyone jabbed, stating: “No one should be in any doubt: there is a tidal wave of Omicron coming.”
So far, 23 million people have received a third dose, equating to 40 per cent of the population aged 12 and over.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments